Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2007 1
2008 1
2010 1
2011 1
2012 2
2016 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
New Metabolic Influencer on Oxytocin Release: The Ghrelin.
Szabó R, Ménesi R, H Molnár A, Szalai Z, Daruka L, Tóth G, Gardi J, Gálfi M, Börzsei D, Kupai K, Juhász A, Radács M, László FA, Varga C, Pósa A. Szabó R, et al. Among authors: laszlo fa. Molecules. 2019 Feb 18;24(4):735. doi: 10.3390/molecules24040735. Molecules. 2019. PMID: 30781678 Free PMC article.
Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.
Gálfi M, Radács M, Molnár Z, Budai I, Tóth G, Pósa A, Kupai K, Szalai Z, Szabó R, Molnár HA, Gardi J, László FA, Varga C. Gálfi M, et al. Among authors: laszlo fa. J Mol Neurosci. 2016 Dec;60(4):525-530. doi: 10.1007/s12031-016-0850-4. Epub 2016 Oct 17. J Mol Neurosci. 2016. PMID: 27752928
The osmotically and histamine-induced enhancement of the plasma vasopressin level is diminished by intracerebroventricularly administered orexin in rats.
Kis GK, Molnár AH, Daruka L, Gardi J, Rákosi K, László F, László FA, Varga C. Kis GK, et al. Among authors: laszlo fa. Pflugers Arch. 2012 Apr;463(4):531-6. doi: 10.1007/s00424-012-1080-4. Epub 2012 Feb 16. Pflugers Arch. 2012. PMID: 22350729
Effects of orexin-monoaminergic interactions on oxytocin secretion in rat neurohypophyseal cell cultures.
Ocskó T, Gálfi M, Radács M, Molnár Z, Kis GK, Rákosi K, Molnár AH, László F, László FA, Varga C. Ocskó T, et al. Among authors: laszlo fa. Regul Pept. 2012 Apr 10;175(1-3):43-8. doi: 10.1016/j.regpep.2012.01.002. Epub 2012 Jan 24. Regul Pept. 2012. PMID: 22280801
Inhibitory effect of galanin on adrenaline- and noradrenaline-induced increased oxytocin secretion in rat neurohypophyseal cell cultures.
Radács M, Molnár AH, László FA, Varga C, László F, Gálfi M. Radács M, et al. Among authors: laszlo fa. J Mol Neurosci. 2010 Sep;42(1):59-66. doi: 10.1007/s12031-010-9331-3. Epub 2010 Feb 10. J Mol Neurosci. 2010. PMID: 20146024
Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
Molnár AH, Varga C, Berkó A, Rojik I, Párducz A, László F, László FA. Molnár AH, et al. Among authors: laszlo fa. Prog Brain Res. 2008;170:519-25. doi: 10.1016/S0079-6123(08)00439-1. Prog Brain Res. 2008. PMID: 18655905
Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo.
Nemcsik J, Morschl E, Egresits J, Kordás K, László F, László FA, Pávó I. Nemcsik J, et al. Among authors: laszlo fa. Eur J Pharmacol. 2004 Jul 14;495(2-3):179-84. doi: 10.1016/j.ejphar.2004.05.039. Eur J Pharmacol. 2004. PMID: 15249168
Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260.
Molnár AH, Varga C, Janáky T, Tóth G, Tóth G, Farkas J, László F, László FA. Molnár AH, et al. Among authors: laszlo fa. Regul Pept. 2007 Jun 7;141(1-3):12-8. doi: 10.1016/j.regpep.2006.12.011. Epub 2007 Jan 4. Regul Pept. 2007. PMID: 17258819
The effects of orexins on monoaminerg-induced changes in vasopressin level in rat neurohypophyseal cell cultures.
Kis GK, Ocskó T, Gálfi M, Radács M, Molnár Z, Rákosi K, Molnár AH, László F, Varga C, László FA. Kis GK, et al. Among authors: laszlo fa. Neuropeptides. 2011 Dec;45(6):385-9. doi: 10.1016/j.npep.2011.08.001. Epub 2011 Sep 9. Neuropeptides. 2011. PMID: 21907406
Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats.
Nemcsik J, Kordás K, Egresits J, László F, László FA, Pávó I, Morschl E. Nemcsik J, et al. Among authors: laszlo fa. Eur J Pharmacol. 2004 Sep 13;498(1-3):195-202. doi: 10.1016/j.ejphar.2004.07.057. Eur J Pharmacol. 2004. PMID: 15363995
11 results
Jump to page
Feedback